Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Chronic Heart Failure

Free Subscription 13.02.2023 3 Am J Cardiol 4 Cardiovasc Res 2 Circ Cardiovasc Imaging 2 Circ Res 3 Circulation 4 Int J Cardiol 1 J Am Coll Cardiol 2 J Card Fail 1 J Cardiol 1 J Cardiovasc Pharmacol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. BUTTAR C, Lakhdar S, Nso N, Guzman-Perez L, et al
   Meta-Analysis Comparing Outcomes of Remote Hemodynamic Assessment Versus Standard Care in Patients With Heart Failure.
   Am J Cardiol. 2023;192:79-87.
   PubMed         Abstract available
   
   
2. MADNAWAT H, Atallah I, Ahmad A, Harjai K, et al
   Biventricular Noncompaction Cardiomyopathy in a Patient Presenting With a New Cerebrovascular Event.
   Am J Cardiol. 2023;190:110-112.
   PubMed         Abstract available
   
   
3. INGALLINA G, Rampa L, Dicandia M, Boccellino A, et al
   Anesthesia-Induced Intraprocedural Downgrading of Mitral Regurgitation During Transcatheter Edge-to-Edge Repair.
   Am J Cardiol. 2022;190:25-31.
   PubMed         Abstract available
   
   

   
   Cardiovasc Res

4. 
   Corrigendum to: Global burden of heart failure: a comprehensive and updated review of epidemiology.
   Cardiovasc Res. 2023 Feb 9:cvad026. doi: 10.1093.
   PubMed        
   
   
5. CAPONE F, Sotomayor-Flores C, Bode D, Wang R, et al
   Cardiac metabolism in HFpEF: from fuel to signalling.
   Cardiovasc Res. 2023;118:3556-3575.
   PubMed         Abstract available
   
   
6. PORCARI A, Fontana M, Gillmore JD
   Transthyretin cardiac amyloidosis.
   Cardiovasc Res. 2023;118:3517-3535.
   PubMed         Abstract available
   
   
7. DULCE RA, Kanashiro-Takeuchi RM, Takeuchi LM, Salerno AG, et al
   Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction.
   Cardiovasc Res. 2023;118:3586-3601.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Imaging

8. CARLUCCIO E, Cameli M, Rossi A, Dini FL, et al
   Left Atrial Strain in the Assessment of Diastolic Function in Heart Failure: A Machine Learning Approach.
   Circ Cardiovasc Imaging. 2023 Feb 8:e014605. doi: 10.1161/CIRCIMAGING.122.014605
   PubMed         Abstract available
   
   
9. SANNINO A, Delgado V
   Left Atrial Reservoir Strain and Machine Learning: Augmenting Clinical Care in Heart Failure Patients.
   Circ Cardiovasc Imaging. 2023 Feb 8:e15154. doi: 10.1161/CIRCIMAGING.123.015154.
   PubMed        
   
   

   
   Circ Res

10. SAWICKI KT, De Jesus A, Ardehali H
    Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets.
    Circ Res. 2023;132:379-396.
    PubMed         Abstract available
    
    
11. PI H, Xia L, Ralph DD, Rayner SG, et al
    Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes.
    Circ Res. 2023;132:254-266.
    PubMed         Abstract available
    
    

    
    Circulation

12. SCHULZE PC, Bogoviku J, Westphal J, Aftanski P, et al
    Response by Schulze et al to Letter Regarding Article, "Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF)".
    Circulation. 2023;147:e75.
    PubMed        
    
    
13. CAPONE F, Vettor R, Schiattarella GG
    Cardiometabolic HFpEF: NASH of the Heart.
    Circulation. 2023;147:451-453.
    PubMed        
    
    
14. SAWAMI K, Tanaka A, Node K
    Letter by Sawami et al Regarding Article, "Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF)".
    Circulation. 2023;147:e73-e74.
    PubMed        
    
    

    
    Int J Cardiol

15. KOSTANJSEK L, Ardissino M, Moussa O, Rayes B, et al
    Effect of bariatric surgery on the incidence of heart failure: A propensity score matched nationwide cohort study.
    Int J Cardiol. 2023 Feb 2:S0167-5273(23)00169.
    PubMed         Abstract available
    
    
16. NGUYEN BN, Mital S, Bugden S, Nguyen HV, et al
    Cost-effectiveness of dapagliflozin and empagliflozin for treatment of heart failure with reduced ejection fraction.
    Int J Cardiol. 2023 Jan 31:S0167-5273(23)00120.
    PubMed         Abstract available
    
    
17. ZAMPIERI M, Salvi S, Fumagalli C, Argiro A, et al
    Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation.
    Int J Cardiol. 2023;374:65-72.
    PubMed         Abstract available
    
    
18. LIU Y, Li Y, Zhang J, Zhao Y, et al
    Pregnancy outcomes of women with Eisenmenger syndrome: A single-center study.
    Int J Cardiol. 2023;374:35-41.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

19. KOSIBOROD MN, Bhatt AS, Claggett BL, Vaduganathan M, et al
    Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction.
    J Am Coll Cardiol. 2023;81:460-473.
    PubMed         Abstract available
    
    

    
    J Card Fail

20. BERNHARDT AM, Copeland H, Deswal A, Gluck J, et al
    The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support.
    J Card Fail. 2023 Feb 2:S1071-9164(22)01185.
    PubMed        
    
    
21. SEPEHRVAND N, Nabipoor M, Youngson E, McAlister FA, et al
    Time to triple therapy in patients with de novo heart failure with reduced ejection fraction: a population-based study.
    J Card Fail. 2023 Feb 6:S1071-9164(23)00034.
    PubMed         Abstract available
    
    

    
    J Cardiol

22. LI M, Ma W, Fan F, Yi T, et al
    Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    J Cardiol. 2023 Feb 7:S0914-5087(23)00021-7. doi: 10.1016/j.jjcc.2023.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

23. ZHENG S, Zhang Y, Gu L, Ma K, et al
    Renal Safety of Sacubitril/Valsartan: A Meta-Analysis of Randomized Controlled Trials.
    J Cardiovasc Pharmacol. 2023;81:93-103.
    PubMed         Abstract available
    
    

    
    PLoS One

24. ALCOBERRO L, Moliner P, Vime J, Jimenez-Marrero S, et al
    Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failure.
    PLoS One. 2023;18:e0279815.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: